Skip to search formSkip to main contentSkip to account menu

Pariet

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Rabeprazole (Aciphex, Alfence, Pariet) is a proton pump inhibitor (PPI) used for the treatment of adults with conditions… 
2009
2009
Background  In 2003, British Columbia’s PharmaCare programme implemented a drug reimbursement policy called Therapeutic… 
2008
2008
A simple and sensitive HPLC method for the analysis of rabeprazole in plasma is described using UV detection in the presence of… 
2005
2005
Total expenditure under the Community Drugs Schemes in Ireland on the proton pump inhibitors (PPI's) used for the management of… 
Review
2005
Review
2005
  • A. Sharara
  • Expert review of anti-infective therapy
  • 2005
  • Corpus ID: 46503593
Proton pump inhibitors have become one of the cornerstones in the treatment of Helicobacter pylori infection. Rabeprazole (Pariet… 
2002
2002
Three groups of patients were studied with the purpose of assessing the efficiency of the application of Pariet in the complex… 
2002
2002
The results on estimation of efficiency and safety of monotherapy by Rabeprasol in dose 20 mg per day in treatment of the… 
2002
2002
Three groups of patients were studied with the purpose of assessing the efficiency of the application of Pariet in the complex… 
Review
2001
Review
2001
UNLABELLED Rabeprazole is an inhibitor of the gastric proton pump. It causes dose-dependent inhibition of acid secretion. In 8… 
2001
2001
The cAMP/cAMP‐dependent protein kinase (PKA) signaling pathway has been implicated in synaptic plasticity changes and memory…